These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 6445503)

  • 21. Defective membrane repair in dysferlin-deficient muscular dystrophy.
    Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
    Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Progressive musclar dystrophy in the experience of the Pediatric Clinic of Florence. Longitudinal study of 43 subjects].
    Adami Lami Conti C; Calandi C; Nistri R; Aulisi A; Bucciolini MG; Vannelli G; Ragazzini F
    Minerva Pediatr; 1981 May; 33(9):385-412. PubMed ID: 7019663
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative study of the enzyme activity of muscle tissue of normal children and children with progressive muscular dystrophy at different stages of the disease].
    Hooft C; De Laey P; Lambert Y
    Rev Fr Etud Clin Biol; 1966 May; 11(5):510-1. PubMed ID: 5938397
    [No Abstract]   [Full Text] [Related]  

  • 24. [Membrane theory of the pathogenesis of progressive muscular dystrophy].
    Badalian LO; Temin PA; Il'in IL; Kovaleva MIu; Dzutova ED
    Klin Med (Mosk); 1982 Oct; 60(10):13-6. PubMed ID: 6757558
    [No Abstract]   [Full Text] [Related]  

  • 25. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels.
    Muir WA; Knoke J; Martin A; Vignos P; McErlean A
    Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle enzymes and isoenzymes in Emery-Dreifuss muscular dystrophy.
    Bialer MG; Bruns DE; Kelly TE
    Clin Chem; 1990 Mar; 36(3):427-30. PubMed ID: 2311208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.
    Cox GA; Cole NM; Matsumura K; Phelps SF; Hauschka SD; Campbell KP; Faulkner JA; Chamberlain JS
    Nature; 1993 Aug; 364(6439):725-9. PubMed ID: 8355788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Structural and ultrastructural changes in the skeletal muscles of patients in the early stages of Duchenne muscular dystrophy and "possible" carriers].
    Bucciolini Di Sagni MG; Vannelli Gori G; Oriolo RA
    Boll Soc Ital Biol Sper; 1982 May; 58(10):632-8. PubMed ID: 7115577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
    Wang S; Shen D
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early symptoms of Duchenne muscular dystrophy--description of cases of an 18-month-old and an 8-year-old patient.
    Iwańczak F; Stawarski A; Potyrała M; Siedlecka-Dawidko J; Agrawal GS
    Med Sci Monit; 2000; 6(3):592-5. PubMed ID: 11208376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Contribution to the study of the enzymology of primary myopathies of childhood].
    Vitetta M
    Biol Lat; 1965; 18(4):359-66. PubMed ID: 5871253
    [No Abstract]   [Full Text] [Related]  

  • 32. Protein degradation in cultured skeletal muscle from Duchenne muscular dystrophy patients.
    Neville HE; Harrold S
    Muscle Nerve; 1985; 8(3):253-7. PubMed ID: 4058470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel.
    Iwata Y; Katanosaka Y; Arai Y; Komamura K; Miyatake K; Shigekawa M
    J Cell Biol; 2003 Jun; 161(5):957-67. PubMed ID: 12796481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [On Becker's benign muscular dystrophy: study of a family with 10 affected members in 6 generations].
    Caruso G; Campanella G
    Acta Neurol (Napoli); 1968; 23(4):709-31. PubMed ID: 5747395
    [No Abstract]   [Full Text] [Related]  

  • 35. Red blood cell alterations in muscular dystrophy: the role of lipids.
    Plishker GA; Appel SH
    Muscle Nerve; 1980; 3(1):70-81. PubMed ID: 6246420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical relationships between muscle and erythrocyte membrane. Interpretations with respect to Duchenne muscular dystrophy.
    Roses AD; Herbstreith MH; Metcalf BS; Hartwig GB
    Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):463-8. PubMed ID: 285848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular organization of erythrocyte membranes in Duchenne muscular dystrophy].
    Falcioni AM; Ferretti G; Mazzanti L; Curatola G
    Boll Soc Ital Biol Sper; 1981 Dec; 57(23):2307-12. PubMed ID: 6279127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
    Ceccarelli A; Leone P
    Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497
    [No Abstract]   [Full Text] [Related]  

  • 39. Proteins of muscle subcellular fractions in Duchenne progressive muscular dystrophy stained with "stains-all" cationic carbocyanine dye and with Coomassie Blue.
    Niebroj-Dobosz I; Kornguth S; Schutta H; Siegel FL; Hausmanowa-Petrusewicz I
    Muscle Nerve; 1989 Apr; 12(4):273-80. PubMed ID: 2770780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased water permeability of erythrocyte membranes in patients with Duchenne muscular dystrophy.
    Serbu AM; Marian A; Popescu O; Pop VI; Borza V; Benga I; Benga G
    Muscle Nerve; 1986; 9(3):243-7. PubMed ID: 3702912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.